Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Gen Virol ; 101(6): 635-644, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32375946

RESUMEN

Human cytomegalovirus latency and reactivation is a major source of morbidity in immune-suppressed patient populations. Lifelong latent infections are established in CD34+progenitor cells in the bone marrow, which are hallmarked by a lack of major lytic gene expression, genome replication and virus production. A number of studies have shown that inhibition of the major immediate early promoter (MIEP) - the promoter that regulates immediate early (IE) gene expression - is important for the establishment of latency and that, by extension, reactivation requires reversal of this repression of the MIEP. The identification of novel promoters (termed ip1 and ip2) downstream of the MIEP that can drive IE gene expression has led to speculation over the precise role of the MIEP in reactivation. In this study we show that IE transcripts arise from both the MIEP and ip2 promoter in the THP1 cell macrophage cell line and also CD14+monocytes stimulated with phorbol ester. In contrast, we show that in in vitro generated dendritic cells or macrophages that support HCMV reactivation IE transcripts arise predominantly from the MIEP and not the intronic promoters. Furthermore, inhibition of histone modifying enzyme activity confirms the view that the MIEP is predominantly regulated by the activity of cellular chromatin. Finally, we observe that ip2-derived IE transcription is cycloheximide-sensitive in reactivating DCs, behaviour consistent with an early gene designation. Taken together, these data argue that MIEP activity is still important for HCMV reactivation but ip2 activity could play cell-type-specific roles in reactivation.


Asunto(s)
Citomegalovirus/genética , Células Dendríticas/virología , Genes Inmediatos-Precoces/genética , Proteínas Inmediatas-Precoces/genética , Regiones Promotoras Genéticas/genética , Células Madre/virología , Transcripción Genética/genética , Cromatina/genética , Infecciones por Citomegalovirus/virología , Regulación Viral de la Expresión Génica/genética , Humanos , Macrófagos/virología , Monocitos/virología , Células THP-1/virología , Activación Viral/genética , Latencia del Virus/genética
2.
J Infect Dis ; 218(suppl_5): S327-S334, 2018 11 22.
Artículo en Inglés | MEDLINE | ID: mdl-30085081

RESUMEN

A better understanding of the mechanisms used by Ebola virus to disable the host immune system and spread the infection are of great importance for development of new therapeutic strategies. We demonstrate that treatment of monocytic cells with Ebola virus shed glycoprotein (GP) promotes their differentiation resulting in increased infection and cell death. The effects were inhibited by blocking Toll-like receptor 4 pathway. In addition, high levels of shed GP were detected in supernatants of cells treated with Ebola vaccines. This study highlights the role of shed GP in Ebola pathogenesis and also in adverse effects associated with Ebola vaccines.


Asunto(s)
Muerte Celular/fisiología , Diferenciación Celular/fisiología , Ebolavirus/metabolismo , Glicoproteínas/metabolismo , Monocitos/metabolismo , Receptor Toll-Like 4/metabolismo , Muerte Celular/inmunología , Diferenciación Celular/inmunología , Vacunas contra el Virus del Ébola/inmunología , Ebolavirus/inmunología , Glicoproteínas/inmunología , Fiebre Hemorrágica Ebola/inmunología , Fiebre Hemorrágica Ebola/metabolismo , Fiebre Hemorrágica Ebola/virología , Interacciones Huésped-Patógeno/inmunología , Interacciones Huésped-Patógeno/fisiología , Humanos , Monocitos/inmunología , Monocitos/fisiología , Monocitos/virología , Células THP-1/metabolismo , Células THP-1/fisiología , Células THP-1/virología , Proteínas del Envoltorio Viral/metabolismo
3.
Viruses ; 10(1)2017 12 30.
Artículo en Inglés | MEDLINE | ID: mdl-29301198

RESUMEN

Human immunodeficiency virus type-1 (HIV-1) infection of monocyte/macrophages is modulated by the levels of entry receptors cluster of differentiation 4 (CD4) and C-C chemokine receptor type 5 (CCR5), as well as by host antiviral restriction factors, which mediate several post-entry blocks. We recently identified two microRNAs, miR-221 and miR-222, which limit HIV-1 entry during infection of monocyte-derived macrophages (MDMs) by down-regulating CD4 expression. Interestingly, CD4 is also down-regulated during the differentiation of monocytes into macrophages. In this study, we compared microRNA expression profiles in primary monocytes and macrophages by RNAseq and found that miR-221/miR-222 are enhanced in macrophages. We took advantage of the monocytic THP-1 cell line that, once differentiated, is poorly susceptible to HIV-1. Accordingly, we found that CD4 levels are very low in THP-1 differentiated cells and that this down-regulation of the virus receptor is the result of miR-221/miR-222 up-regulation during differentiation. We thus established a THP-1 cell line stably expressing a modified CD4 (THP-1-CD4R) that is not modulated by miR-221/miR-222. We show that in contrast to parental THP-1, this line is productively infected by HIV-1 following differentiation, sustaining efficient HIV-1 CD4-dependent replication and spread. This new THP-1-CD4R cell line represents a useful tool for the study of HIV-1-macrophage interactions particularly in contexts where spreading of viral infection is necessary.


Asunto(s)
Antígenos CD4/genética , Diferenciación Celular , VIH-1/fisiología , MicroARNs/genética , Receptores Virales/genética , Células THP-1/virología , Internalización del Virus , Antagomirs/farmacología , Antígenos CD4/metabolismo , Células Cultivadas , Regulación hacia Abajo/efectos de los fármacos , Infecciones por VIH/metabolismo , Infecciones por VIH/virología , Humanos , Macrófagos/fisiología , Macrófagos/virología , MicroARNs/antagonistas & inhibidores , MicroARNs/metabolismo , Monocitos/fisiología , Monocitos/virología , Receptores Virales/metabolismo , Células THP-1/fisiología , Regulación hacia Arriba/efectos de los fármacos , Replicación Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA